Startseite › Metastasierender Krebs › Distrikt Columbia › Washington
Klinische Studien zu Metastasierender Krebs in Washington, DC
43 Studien zu Metastasierender Krebs suchen Teilnehmer an Standorten in und um Washington (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Teilnehmer gesuchtPhase 2
- Walter Reed National Military Medical Center, Bethesda · 7 mi entfernt
- National Institutes of Health Clinical Center, Bethesda · 7 mi entfernt
The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer
Teilnehmer gesuchtPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi entfernt
A Study of ASP3082 in Adults With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Georgetown University Hospital, Washington D.C.
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Teilnehmer gesuchtPhase 2/3
- Georgetown University, Washington D.C.
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Teilnehmer gesuchtPhase 2
- The George Washington Medical facility Associates, Washington D.C.
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Teilnehmer gesuchtPhase 2/3
- Georgetown University Medical Center - Department of Pharmacy, Oncology Pharmacy, Washington D.C.
- Georgetown University Medical Center, Washington D.C.
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Teilnehmer gesuchtPhase 3
- Maryland Oncology Hematology, P.A., Silver Spring · 7 mi entfernt
- Maryland Oncology Hematology, P.A., Bethesda · 7 mi entfernt
- Maryland Oncology Hematology, P.A., Largo · 11 mi entfernt
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Teilnehmer gesuchtPhase 1/2
- Georgetown University Medical Center, Washington D.C.
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Teilnehmer gesuchtPhase 3
- MedStar Washington Hospital Center, Washington D.C.
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Teilnehmer gesuchtPhase 3
- MedStar Washington Hospital Center, Washington D.C.
- American Oncology Partners, PA, Bethesda · 7 mi entfernt
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
Teilnehmer gesuchtPhase 1/2
- MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center ( Site 0026), Washington D.C.
Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid Cancers
Teilnehmer gesuchtPhase 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi entfernt
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Clinical Study Site, Washington D.C.
The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
Teilnehmer gesuchtPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi entfernt
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
Teilnehmer gesuchtPhase 2
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi entfernt
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Teilnehmer gesuchtPhase 3
- Sibley Memorial Hospital, Washington D.C.
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Teilnehmer gesuchtPhase 1/2
- Avenzo Therapeutics Recruiting Site, Washington D.C.
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Teilnehmer gesuchtPhase 3
- The Center for Cancer and Blood Disorders a division of American Oncology Partners, P.A., Bethesda · 7 mi entfernt
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
Teilnehmer gesuchtPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi entfernt
Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi entfernt
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
Teilnehmer gesuchtPhase 2
- Research Site, Washington D.C.
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers
Teilnehmer gesuchtPhase 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi entfernt
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
Teilnehmer gesuchtPhase 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi entfernt
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
Teilnehmer gesuchtPhase 1/2
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi entfernt
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Teilnehmer gesuchtPhase 3
- Research Site, Washington D.C.
- Research Site, Silver Spring · 7 mi entfernt
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1/2
- George Washington University, Washington D.C.
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
Teilnehmer gesuchtPhase 3
- MedStar Washington Hospital Center, Washington D.C.
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Teilnehmer gesuchtPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi entfernt
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Teilnehmer gesuchtPhase 1/2
- Georgetown University Medical Center, Washington D.C.
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Teilnehmer gesuchtPhase 3
- American Oncology Partners, P.A., Bethesda · 7 mi entfernt
Studying TAK-243 in Patients With Advanced Cancer
Teilnehmer gesuchtPhase 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi entfernt
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Teilnehmer gesuchtPhase 2/3
- The Center for Cancer and Blood Disorders, Bethesda · 7 mi entfernt
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- Cancer Support Community Research & Training Institute, Washington D.C.
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Teilnehmer gesuchtPhase 3
- The George Washington University, Washington D.C.
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Teilnehmer gesuchtPhase 2/3
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Teilnehmer gesuchtPhase 2/3
- Georgetown University Medical Center, Washington D.C.
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- National Cancer Institute, Bethesda · 7 mi entfernt
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
Teilnehmer gesuchtPhase 1
- Georgetown University Medical Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1
- American Oncology Partners of Maryland, Bethesda · 7 mi entfernt
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Teilnehmer gesuchtPhase 1/2
- The George Washington University Cancer Center (site 212), Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Teilnehmer gesuchtBeobachtungsstudie
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mi entfernt
- Massive Bio SYNERGY-AI site, Bethesda · 7 mi entfernt
Metastasierender Krebs-Studien in anderen Städten
- Houston, TX104 Studien
- New York City, NY93 Studien
- Nashville, TN70 Studien
- Boston, MA63 Studien
- Los Angeles, CA57 Studien
- St. Louis, MO54 Studien
- Arlington, VA53 Studien
- Philadelphia, PA46 Studien
- Chicago, IL45 Studien
- San Antonio, TX44 Studien
- Dallas, TX42 Studien
- Seattle, WA39 Studien
Weitere Studien in Washington
- Krebs (alle Arten)58 Studien
- Nichtkleinzelliges Lungenkarzinom55 Studien
- Brustkrebs46 Studien
- Lungenkrebs41 Studien
- Prostatakrebs38 Studien
- Adipositas33 Studien
- Kolorektales Karzinom29 Studien
- Herz-Kreislauf-Erkrankungen28 Studien
- Blasenkrebs26 Studien
- Akute myeloische Leukämie24 Studien
- Eierstockkrebs23 Studien
- Lymphom23 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 06.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.